Showing results (51-60 of 16,137) with videos related to

Sort By:
Pageof 1,614
European Journal of Medicinal Chemistry|May 29, 2016
Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitorsQian Li, Yangyang Zhai, Wen Luo, et al.
European Journal of Medicinal Chemistry|May 24, 2016
Antidepressant-like effects and mechanisms of flavonoids and related analoguesLi-Ping Guan, Bing-Yu Liu
European Journal of Medicinal Chemistry|September 1, 2014
Current research on hyaluronic acid-drug bioconjugatesHaiqun Zhang, Siling Huang, Xiaoye Yang, et al.
European Journal of Medicinal Chemistry|July 30, 2015
Design, synthesis and anticancer activity of Michael-type thiol adducts of α-santonin analogue with exocyclic methyleneJabeena Khazir, Darren L Riley, Gousia Chashoo, et al.
European Journal of Medicinal Chemistry|August 12, 2015
Design, characterization and in vitro evaluation of novel shell crosslinked poly(butylene adipate)-co-N-succinyl chitosan nanogels containing loteprednol etabonate: A new system for therapeutic effect enhancement via controlled drug deliveryFarzaneh Hashemi Nasr, Sepideh Khoee
European Journal of Medicinal Chemistry|August 18, 2015
Synthesis and in vitro antitumor evaluation of betulin acid ester derivatives as novel apoptosis inducersSheng-Jie Yang, Ming-Chuan Liu, Hong-Mei Xiang, et al.
European Journal of Medicinal Chemistry|August 16, 2015
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motifWenxin Li, Xiao Li, Erik De Clercq, et al.
European Journal of Medicinal Chemistry|August 16, 2015
Antitumor activity of endoperoxide-iron chelator conjugates-design, synthesis and biological evaluationXing Yan, Yang Yu, Peng Ji, et al.
European Journal of Medicinal Chemistry|August 21, 2015
Design and synthesis of 2-phenylnaphthalenoids and 2-phenylbenzofuranoids as DNA topoisomerase inhibitors and antitumor agentsHuilin Hao, Wang Chen, Jing Zhu, et al.
European Journal of Medicinal Chemistry|May 1, 2016
An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone coreZilan Song, Zongjun Xia, Yinchun Ji, et al.
Pageof 1,614